Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (311-320 of 436) with videos related to

Pageof 44
Sort By:
Seminars in Arthritis and Rheumatism|August 3, 2022
Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepanciesChristian Lynæs, Maria Lynæs, Lee S Simon, et al.
The Journal of Rheumatology|November 3, 2005
Outcome measures in psoriatic arthritisDafna D Gladman, Philip J Mease, Gerald Krueger, et al.
Arthritis and Rheumatism|August 29, 2009
Novel evidence-based systemic lupus erythematosus responder indexRichard A Furie, Michelle A Petri, Daniel J Wallace, et al.
Seminars in Arthritis and Rheumatism|June 2, 2022
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working groupJosé B Negrón, Maria A Lopez-Olivo, Loreto Carmona, et al.
Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.
Annals of the Rheumatic Diseases|July 10, 2012
Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensusSusan J Bartlett, Sarah Hewlett, Clifton O Bingham, et al.
The Journal of Rheumatology|May 3, 2015
Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014William Tillett, Lihi Eder, Niti Goel, et al.
Rheumatology Advances in Practice|November 15, 2021
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort studyMarie Skougaard, Tanja S Jørgensen, Mia J Jensen, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
The Journal of Rheumatology|August 3, 2015
Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACTKristine Phillips, Ann Taylor, Philip J Mease, et al.
Pageof 44

Showing results (311-320 of 436) with videos related to

Sort By:
Pageof 44
Seminars in Arthritis and Rheumatism|August 3, 2022
Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepanciesChristian Lynæs, Maria Lynæs, Lee S Simon, et al.
The Journal of Rheumatology|November 3, 2005
Outcome measures in psoriatic arthritisDafna D Gladman, Philip J Mease, Gerald Krueger, et al.
Arthritis and Rheumatism|August 29, 2009
Novel evidence-based systemic lupus erythematosus responder indexRichard A Furie, Michelle A Petri, Daniel J Wallace, et al.
Seminars in Arthritis and Rheumatism|June 2, 2022
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working groupJosé B Negrón, Maria A Lopez-Olivo, Loreto Carmona, et al.
Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.
Annals of the Rheumatic Diseases|July 10, 2012
Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensusSusan J Bartlett, Sarah Hewlett, Clifton O Bingham, et al.
The Journal of Rheumatology|May 3, 2015
Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014William Tillett, Lihi Eder, Niti Goel, et al.
Rheumatology Advances in Practice|November 15, 2021
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort studyMarie Skougaard, Tanja S Jørgensen, Mia J Jensen, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
The Journal of Rheumatology|August 3, 2015
Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACTKristine Phillips, Ann Taylor, Philip J Mease, et al.
Pageof 44